36 completed, 4 unknown, 2 suspended, 1 recruiting. 19 Phase 3, 15 Phase 1, 7 Phase 2, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 19 | Completed 14, Unknown 3, Recruiting 1, Suspended 1 |
| Phase 1 | 15 | Completed 15 |
| Phase 2 | 7 | Completed 3, Unknown 2, Suspended 1, Withdrawn 1 |
| Phase 4 | 2 | Completed 2 |
Follow Laboratorios Silanes S.A. de C.V.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Etoricoxib/Betamethasone Combination in Acute Bursitis, Tendinitis and Synovitis Fixed Dose Etoricoxib + Betamethasone, Monotherapy Etoricoxib - Bursitis, Tendinitis | Phase 3 | Completed | Laboratorios Silanes S.A. de C.V. | 89 | 2025-05-14 | 2026-01-08 |
| Efficacy Anda Safety of Etoricoxib With Betamethasone for the Treatment of Acute Gout Arthritis Etoricoxib + Betamethasone fixed dose, Etoricoxib fixed dose - Gout Arthritis, Gout Attack | Phase 3 | Recruiting | Laboratorios Silanes S.A. de C.V. | 72 | 2025-01-27 | 2025-04-03 |
| Comparative Bioavailability Study Between Ticagrelor and ASA Administered Individually or in Combination. A1: Ticagrelor / Acetylsalicylic acid in fixed dose combination capsule. (Laboratorios Silanes S.A. de C.V.), A2: Ticagrelor (BRILINTA®, AstraZeneca S.A. de C.V.) A3: Acetylsalicylic Acid (ASPIRINA JUNIOR®, Bayer de México S.A. de C.V.) - Healthy | Phase 1 | Completed | Laboratorios Silanes S.A. de C.V. | 24 | 2025-01-13 | 2026-03-02 |
| Confirmatory Study on the Efficacy and Safety of the Fixed-dose Combination of Desloratadine/Betamethasone Versus Desloratadine Desloratadine / Betamethasone in fixed dose, Desloratadine - Allergic Rhinitis | Phase 3 | Completed | Laboratorios Silanes S.A. de C.V. | 70 | 2024-11-11 | 2026-07-23 |
| Efficacy and Safety of Etoricoxib/Tizanidine Versus Etoricoxib for Acute Low Back Pain Associated to Muscle Spasm Etoricoxib + Tizanidine fixed dose, Etoricoxib fixed dose - Acute Low-back Pain, Muscle Spasm; Back Pain | Phase 3 | Completed | Laboratorios Silanes S.A. de C.V. | 136 | 2024-09-18 | 2026-01-09 |
| Efficacy and Safety of Celecoxib/Acetaminophen Versus Celecoxib for Diagnosed Osteoarthritis in Acute Exacerbation Celecoxib + Acetaminophen, Celecoxib - Joint Pain, Knee Osteoarthritis | Phase 3 | Completed | Laboratorios Silanes S.A. de C.V. | 231 | 2024-09-09 | 2026-10-23 |
| Efficacy and Safety in the Combination of Ibuprofen / Loratadine Versus Ibuprofen Versus Loratadine Ibuprofen + Loratadine fixed dose, Ibuprofen, Loratadine - Common Cold | Phase 3 | Completed | Laboratorios Silanes S.A. de C.V. | 177 | 2024-06-24 | 2026-10-23 |
| Efficacy and Safety of Etoricoxib/Cyanocobalamin Versus Etoricoxib for Acute Low Back Pain Etoricoxib + Cyanocobalamin fixed dose, Etoricoxib fixed dose - Acute Low-back Pain | Phase 3 | Completed | Laboratorios Silanes S.A. de C.V. | 190 | 2024-04-26 | 2024-11-27 |
| Efficacy and Safety in the Combination of Celecoxib / Pregabalin / Vitamin B for Low Back Chronic Pain Celecoxib+Pregabalin+Vitamin B fixed dose, Celecoxib + Vitamin B fixed dose, Pregabalin + Vitamin B fixed dose - Chronic Low-back Pain | Phase 3 | Completed | Laboratorios Silanes S.A. de C.V. | 192 | 2024-04-11 | 2025-04-04 |
| Oral Combination of Glimepiride/Vildagliptin/Metformin in Patients With T2D and Dual Treatment Failure A1=Glimepiride / Vildagliptin / Metformin (1 mg/ 50 mg/ 500 mg), B2=Glimepiride / Vildagliptin / Metformin (1 mg/ 50 mg/ 500 mg), (A2) Glimepiride/Vildagliptin/Metformin - Type 2 Diabetes | Phase 3 | Completed | Laboratorios Silanes S.A. de C.V. | 162 | 2023-03-21 | 2025-06-10 |
| Comparative Bioavailability Study Between Etoricoxib / Betamethasone Administered Individually or in Combination A1: Etoricoxib / Betamethasone in fixed dose combination tablet. (Laboratorios Silanes S.A. de C.V.), A2: Etoricoxib (Arcoxia®, Laboratorios Schering-Plough, S.A. de C.V.), A3: Betamethasone (Celestone® Pediatric, Laboratorios Schering-Plough, S.A. de C.V.) - Healthy | Phase 1 | Completed | Laboratorios Silanes S.A. de C.V. | 42 | 2022-10-24 | 2026-03-06 |
| Efficacy and Safety of Pregabalin/Tramadol Combination Versus Pregabalin in Acute Pain of Neuropathic Origin Pregabalin 75mg/ Tramadol 50 mg, Pregabalin 75mg - Neuropathic Pain | Phase 3 | Completed | Laboratorios Silanes S.A. de C.V. | 110 | 2022-07-11 | 2023-06-15 |
| Efficacy and Safety of Losartan/Chlorthalidone vs Losartan/Hydrochlorothiazide in Essential Arterial Hypertension Losartan/Chlorthalidone in fixed dose, Losartan + hydrochlorothiazide in fixed dose - Essential Arterial Hypertension | Phase 3 | Completed | Laboratorios Silanes S.A. de C.V. | 163 | 2022-06-30 | 2025-03-13 |
| Efficacy and Safety of the Fixed-dose Combination Atorvastatin/Fenofibrate vs Atorvastatin in Patients With T2D and DLP. Atorvastatin 20 mg / Fenofibrate 160 mg in fixed dose, Atorvastatin (Lipitor ®) - Dyslipidemia Associated With Type II Diabetes Mellitus | Phase 3 | Unknown | Laboratorios Silanes S.A. de C.V. | 78 | 2022-02-15 | 2022-03-02 |
| Efficacy and Safety of Fixed-dose Combination of Etoricoxib/Tramadol vs Acetaminophen/Tramadol for Acute Low Back Pain Etoricoxib 90 mg / Tramadol 50 mg, Acetaminophen 325 mg / Tramadol 37.5 mg - Acute Low Back Pain | Phase 3 | Completed | Laboratorios Silanes S.A. de C.V. | 124 | 2021-11-29 | 2022-04-13 |
| Study to Evaluate the Safety of Sebryl® and Sebryl Plus® in Seborrheic Dermatitis and Psoriasis of Scalp Allantoin/ Coal Tar/ Clioquinol, Allantoin/ Coal Tar/ Clioquinol/ Triclosan - Seborrheic Dermatitis, Psoriasis of Scalp | Completed | Laboratorios Silanes S.A. de C.V. | 90 | 2021-11-29 | 2022-04-13 | |
| Efficacy and Safety of Dexketoprofen/Vitamin B Vs Dexketoprofen for Post-traumatic Cervical Sprain Grade I-II Dexketoprofen/Vitamin B, Dexketoprofen - Acute Low Back Pain | Phase 3 | Completed | Laboratorios Silanes S.A. de C.V. | 174 | 2021-11-23 | 2024-11-13 |
| Study to Evaluate the Safety of the Fixed-dose Combination Rosuvastatin/Ezetimibe for Patients With Dyslipidaemia Rosuvastatin 10 or 20mg /Ezetimibe 10 mg Fixed Dose - Dyslipidemias | Completed | Laboratorios Silanes S.A. de C.V. | 120 | 2021-09-30 | 2022-03-02 | |
| Efficacy and Safety of Metformin Glycinate Compared to Metformin Hydrochloride on the Progression of Type 2 Diabetes Metformin glycinate, Metformin Hydrochloride - Type 2 Diabetes | Phase 3 | Suspended | Laboratorios Silanes S.A. de C.V. | 500 | 2021-08-01 | 2021-06-29 |
| Pharmacokinetic Study Protocol of ANAWIDOW Lyophilized Powder for Solution for Intravenous Use in Fasting Conditions ANAWIDOW [antivenin latrodectus (black widow) equine immune F(ab)2] lyophilized powder for solution 10 mL - Latrodectism | Phase 1 | Completed | Laboratorios Silanes S.A. de C.V. | 16 | 2021-07-01 | 2022-03-02 |
Showing 20 of 44. Sign in to see all of them.
Diabetes Mellitus, Type 2 (9) · Diabetes Mellitus (5) · Acute Pain (4) · Dyslipidemias (3) · Obesity (3) · Pain (3) · Back Pain (2) · Severe Acute Respiratory Syndrome (2) · Arthralgia (1) · Arthritis, Gouty (1) · Bursitis (1) · Chronic Pain (1) · Common Cold (1) · Dermatitis, Seborrheic (1) · Hypersensitivity (1)
Metformin (10) · Etoricoxib (7) · glimepiride (5) · Acetaminophen (4) · Betamethasone (4) · Tramadol (4) · Ibuprofen (3) · Pregabalin (3) · Celecoxib (2) · Chlorthalidone (2) · Ezetimibe (2) · Folic Acid (2) · Losartan (2) · dexketoprofen trometamol (2) · Allantoin (1)
Mexico (43) · Spain (1)
Francisco G Padilla Padilla, M.D (3) · Adelfia Urenda Quezada, M.D (2) · Adelfia Urenda-Quezada, MD (2) · Araceli G Medina Nolasco, M.D (2) · Juan A Peraza Zaldivar, M.D (2) · Rodrigo Suarez-Otero, MD (2) · Salvador Perez-Jaime, MD (2)
PMID 22974412, PMID 10454950, PMID 11756340, PMID 11960602, PMID 12086935, PMID 1490793, PMID 16308421, PMID 17941868, PMID 8569826, PMID 9209206, PMID 9793597, PMID 10801260, PMID 11007769, PMID 12681026, PMID 12815141, PMID 1400291, PMID 14685229, PMID 16155076, PMID 16218959, PMID 16940989, PMID 16953201, PMID 17026483, PMID 17199724, PMID 17560332, PMID 17916599, PMID 18235087, PMID 18955637, PMID 1900072, PMID 19538242, PMID 19918015, PMID 20004680, PMID 20380657, PMID 20577053, PMID 21083513, PMID 21832087, PMID 22231424, PMID 22336956, PMID 23489075, PMID 2648723, PMID 27209166, PMID 27713336, PMID 27778642, PMID 28860855, PMID 29126136, PMID 29541394, PMID 30288088, PMID 30377252, PMID 30414960, PMID 31226023, PMID 31743697